Mianserin
- Level
- Commodity
- Parent
- 51292900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292912This classification denotes a serotonin antagonist and antidepressant agent and adrenergic antagonist with the molecular formula C18H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 250PJI13LM, chemically known as 1,2,3,4,10,14b-hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine but generally known as mianserin, which bears US NIH Compound Identifier 4184. European Medicines Agency schedules Mianserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08939MIG. The term MIANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules mianserin in its Anatomical Therapeutic Chemical (ATC) Classification. MIANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mianserin under HS 29335995 and SITC 51576. As of Q4 2014, MIANSERIN remains the US FDA Preferred Term for this commodity. Mianserin bears US NLM identifiers UMLS ID C0025912 and NCI Concept Code C87209. SMILES: N12C(CN(CC1)C)c1c(Cc3c2cccc3)cccc1.
Same parent
Under 51292900 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.